[Isolation rate of Pseudomonas aeruginosa from clinical materials and its susceptibility to antibiotics].
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002228:Carbenicillin / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D003091:Colistin / Q000494:pharmacology; D005122:Exudates and Transudates / Q000382:microbiology; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D008034:Lincomycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D011113:Polymyxins / Q000494:pharmacology; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000302:isolation & purification*; D012293:Rifampin / Q000494:pharmacology; D013183:Sputum / Q000382:microbiology; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D011113:Polymyxins; D007612:Kanamycin; D002701:Chloramphenicol; D000667:Ampicillin; D008034:Lincomycin; D013752:Tetracycline; D002228:Carbenicillin; D012293:Rifampin; D013307:Streptomycin; D003091:Colistin